Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium

Journal of International Medical Research

Volumn 35, Issue 6, 2007, Pages 803-818

  Diedrichs, Holger ^a   Hagemeister, J ^a   Chi, M ^a   Boelck, B ^a   Muller Ehmsen J ^a   Schneider, C A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Calcineurin; GATA 4; Heart failure; Human Myocardium; Hypertrophy; NFAT 3

Indexed keywords

CALCINEURIN; CALCINEURIN B; CALCINEURIN BETAA; CALCIUM ION; ESTERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 36949013409     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000703500609     Document Type: Article

References (33)

1. Levy D, Garrison RJ, Savage DD, et al: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-1566.
2. Balke CW, Shorofsky SR: Alterations in calcium handling in cardiac hypertrophy and heart failure. Cardiovasc Res 1998; 37: 290-299.
3. Beuckelmann DJ, Nabauer M, Erdmann E: Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992; 85: 1046-1055.
4. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 1995; 92: 3220-3228.
5. Gwathmey JK, Copelas L, MacKinnon R, et al: Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987; 61: 70-76.
6. Feldman MD, Gwathmey JK, Phillips P, et al: Reversal of the force-frequency relationship in working myocardium from patients with end-stage heart failure. J Appl Cardiol 1988; 3: 273-283.
7. Limas CJ, Olivari MT, Goldenberg IF, et al: Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy. Cardiovasc Res 1987; 21: 601-605.
8. Molkentin JD, Lu JR, Antos CL, et al: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-228.
9. De Windt LJ, Lira HW, Taigen T, et al: Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo. Circ Res 2000; 86: 255-263.
10. Haq S, Choukroun G, Lira H, et al: Differential activation of signal transduction pathway in human hearts with hypertrophy versus advanced heart failure. Circulation 2001; 103: 670-677.
11. Lim HW, Molkentin JD: Calcineurin and human heart failure. Nat Med 1999; 5: 246-247.
12. Diedrichs H, Chi M, Boelck B, et al: Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur J Heart Fail 2004; 6: 3-9.
13. Münch G, Boelck B, Karczewski P, et al: Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium. J Mol Cell Cardiol 2002; 34: 321-334.
14. Deryckere F, Gannon F: A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 1994; 16: 405.
15. Ritter O, Hack S, Schuh K, et al: Calcineurin in human heart hypertophy. Circulation 2002; 105: 2265-2269.
16. Sussman MA, Lim HW, Gude N, et al: Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998; 281: 1690 -1693.
17. Lim HW, De Windt LI, Steinberg L, et al: Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 2000; 101: 2431-2437.
18. Eto Y, Yonekura K, Sonda M, et al: Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation 2000; 101: 2134-2137.
19. Hayashida W, Kihara Y, Yasaka A, et al: Cardiac calcineurin during transition from hypertrophy to heart failure in rats. Biochem Biophys Res Commun 2000; 273: 347-351.
20. Shimoyama M, Hayashi D, Takimoto E, et al: Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulatian 1999; 100: 2449-2454.
21. Ding B, Price RL, Borg TK, et al: Pressure overload induces severe hypertrophy in mice treated with cyclosporin, an inhibitor of calcineurin. Circ Res 1999; 84: 729-734.
22. Zhang W, Kowal RC, Rusnak F, et al: Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res 1999; 84: 722-728.
23. Wilkins BJ, Molkentin JD: Calcineurin and cardiac hypertrophy: Where have we been? Where are we going? J Physiol 2002; 541: 1-8.
24. Chow CW, Rincón M, Cavanagh J, et al: Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 1997; 278: 1638-1641.
25. Liang QG, De Windt LJ, Witt SA, et al: The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 2001; 276: 30245-30253.
26. 2+, calcineurin and NFAT. Cell 1999; 96: 611-614.
27. Yang TTC, Xiong QF, Enslen H, et al: Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol Cell Biol 2002; 22: 3892-3904.
28. Morimoto T, Hasegawa K, Wada H, et al: Calcineurin-GATA4 pathway is involved in β-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes. J Biol Chem 2001; 276: 34983-34989.
29. Hasegawa K, Lee SJ, Jobe S, et al: cis-Acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation 1997; 96: 3943-3953.
30. Herzig TC, Jobe SM, Aoki H: Angiotensin II type Iα receptor gene expression in the heart: AP-1 and GATA-4 participate in the responses to pressure overload. Proc Natl Acad Sci USA 1997; 94: 7543-7548.
31. Klee CB, Ren H, Wang X: Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 1998; 273: 13367-13370.
32. Taigen T, De Windt LI, Lim HW, et al: Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2000; 97: 1196-1201,
33. Bueno OF, Brandt EB, Rothenberg ME, et al: Defective T cell development and function in calcineurin A beta-deficient mice. Proc Natl Acad Sci USA 2002; 99: 9398-9403.